Skip to main content
. 2021 Feb 28;13(5):2454. doi: 10.4022/jafib.2454

Table 3. Factors Associated with Self-Reported Moderate Physical Activity: SAGE-AF Study.

Model 1: Adjusting for sociodemographic and clinical factors and smoking status; Model 2: M1 + Geriatric Elements; Model 3: Model 1 + Model 2 + patient reported outcomes; Abbreviations: TIA: Transient Ischemic Attack; CHA2DS2-VASc: Stroke risk assessment; HAS-BLED: Bleeding risk assessment; MOCA: Montreal Cognitive Assessment; PHQ-9: Patient Health Questionnaire 9; GAD-7: Generalized Anxiety Disorder; AFEQT: Atrial Fibrillation Effect on Quality of Life.

Model 1 Adjusted OR (95 % CI) Model 2 Adjusted OR (95 % CI) Model 3 Adjusted OR (95 % CI)
Socio-demographic
Age (yrs)
65-74 Ref. Ref. Ref.
75-84 0.71 (0.51, 0.97) 0.74 (0.53, 1.03) 0.73 (0.52, 1.02)
85+ 0.51 (0.33, 0.79) 0.66 (0.42, 1.05) 0.63 (0.40, 1.00)
Sex (Female vs Male) 0.81 (0.60, 1.10) 0.88 (0.64, 1.21) 0.91 (0.66, 1.25)
Married (No vs Yes) 0.89 (0.69, 1.16) 0.97 (0.74, 1.27) 0.97 (0.74, 1.28)
Non-Hispanic White (Yes vs No) 1.25 (0.88, 1.78) 0.92 (0.63, 1.34) 0.90 (0.61, 1.32)
College Graduate (Yes vs No) 1.36 (1.06, 1.74) 1.19 (0.92, 1.55) 1.16 (0.89, 1.51)
Clinical
Body Mass Index (BMI), kg/m2
Normal Ref. Ref. Ref.
Overweight 0.90 (0.64, 1.27) 0.88 (0.62, 1.25) 0.86 (0.60, 1.23)
Overweight 0.90 (0.64, 1.27) 0.88 (0.62, 1.25) 0.86 (0.60, 1.23)
Obese 0.72 (0.51, 1.02) 0.70 (0.49, 1.00) 0.71 (0.50, 1.02)
Morbidly Obese 0.35 (0.20, 0.61) 0.39 (0.22, 0.70) 0.41 (0.23, 0.73)
Type of AF (%)
Paroxysmal Ref. Ref. Ref.
Persistent 0.98 (0.73, 1.31) 0.99 (0.74, 1.34) 1.04 (0.77, 1.30)
Permanent 0.69 (0.41, 1.17) 0.61 (0.36, 1.04) 0.65 (0.38, 1.11)
Medical History
Alcohol Use 1.32 (0.97, 1.78) 1.16 (0.85, 1.59) 1.12 (0.81, 1.54)
Anemia 1.03 (0.78, 1.35) 1.08 (0.82, 1.44) 1.07 (0.81, 1.42)
Asthma/COPD 0.82 (0.62, 1.10) 0.86 (0.64, 1.16) 0.91 (0.67, 1.22)
Diabetes 0.95 (0.69, 1.31) 1.01 (0.72, 1.41) 0.99 (0.71, 1.38)
Heart Failure 0.69 (0.51, 0.94) 0.79 (0.57, 1.09) 0.83 (0.60, 1.15)
Hypertension 0.91 (0.60, 1.39) 0.99 (0.63, 1.53) 0.95 (0.61, 1.48)
Myocardial Infarction 0.78 (0.55, 1.10) 0.73 (0.51, 1.04) 0.72 (0.51, 1.03)
Peripheral vascular disease 0.78 (0.54, 1.14) 0.79 (0.53, 1.16) 0.78 (0.53, 1.14)
Renal Disease 0.76 (0.54, 1.06) 0.71 (0.50, 1.00) 0.68 (0.48, 0.96)
Stroke/TIA 0.78 (0.48, 1.25) 0.83 (0.50, 1.35) 0.78 (0.48, 1.29)
Risk Scores
CHA2DS2-VASc 1.05 (0.90, 1.22) 1.08 (0.92, 1.27) 1.09 (0.93, 1.28)
HAS-BLED 0.94 (0.79, 1.11) 0.98 (0.82, 1.17) 1.00 (0.84, 1.20)
Geriatric Elements
Gait Speed
Normal Ref. Ref.
Slow 0.45 (0.33, 0.61) 0.44 (0.32, 0.60)
Cognitive Impairment (MOCA) 0.75 (0.57, 0.99) 0.74 (0.56, 0.97)
Social Isolation 0.55 (0.38, 0.81) 0.58 (0.40, 0.84)
Depression (PHQ-9 ≥ 5) 0.68 (0.49, 0.94) 0.76 (0.55, 1.05)
Anxiety (GAD-7 ≥5) 0.85 (0.61, 1.20) 0.93 (0.66, 1.31)
Fall in the Past 6 months 0.92 (0.68, 1.24) 0.96 (0.71, 1.30)
Visual Impairment 0.82 (0.63, 1.07) 0.85 (0.65, 1.12)
Patient Reported Outcome
AFEQT >80 1.64 (1.25, 2.16)